ClinConnect ClinConnect Logo
Search / Trial NCT06571240

Validity and Reliability of the Turkish Version of the Tegner Activity Score

Launched by KIRKLARELI UNIVERSITY · Aug 22, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Tegner Activity Score Anterior Cruciate Ligament Injury Validity Reliability Patient Reported Outcome

ClinConnect Summary

This clinical trial is studying a tool called the Turkish version of the Tegner Activity Score, which helps measure how active people are after having surgery for a knee injury, specifically a torn anterior cruciate ligament (ACL). The researchers want to find out if this score is a reliable and accurate way to assess activity levels in Turkish-speaking patients and learn about its importance in understanding recovery after surgery.

To participate in this study, you need to be at least 18 years old and scheduled for surgery to fix a torn ACL. Unfortunately, if you have certain medical conditions, such as autoimmune diseases or cognitive issues that make it hard to fill out forms, or if you are not fluent in Turkish, you won’t be eligible to join. If you do participate, you can expect to complete some questionnaires about your activity levels, which will help improve how doctors understand recovery for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • to be over 18 years old
  • to undergo surgery for a ruptured anterior cruciate ligament
  • Exclusion Criteria:
  • to have metabolic or autoimmune diseases
  • to undergo revision anterior cruciate ligament surgery or anterior cruciate ligament repair
  • to have cognitive issues that will hinder the completion of the study forms
  • to lack sufficient proficiency in Turkish

About Kırklareli University

Kırklareli University is a distinguished academic institution dedicated to advancing medical research and clinical innovation. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that leverage cutting-edge methodologies and interdisciplinary collaboration. Its research programs are designed to address pressing medical challenges, fostering an environment that encourages rigorous scientific inquiry and ethical practices. By engaging with local and international partners, Kırklareli University aims to contribute significantly to the advancement of medical knowledge and the development of effective therapeutic strategies.

Locations

Ankara, , Turkey

Patients applied

0 patients applied

Trial Officials

Ozan Gür, MSc

Principal Investigator

Kırklareli University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported